Equities

Vera Therapeutics Inc

VERA:NMQ

Vera Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)49.43
  • Today's Change0.89 / 1.83%
  • Shares traded1.00m
  • 1 Year change+287.38%
  • Beta1.0638
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments16111580
Total Receivables, Net------
Total Inventory------
Prepaid expenses11112.86
Other current assets, total----0
Total current assets17212683
Property, plant & equipment, net3.045.22--
Goodwill, net------
Intangibles, net------
Long term investments0.010.060.87
Note receivable - long term------
Other long term assets------
Total assets17613184
LIABILITIES
Accounts payable11121.39
Accrued expenses11145.93
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total--00.38
Total current liabilities22267.69
Total long term debt50254.92
Total debt50254.92
Deferred income tax------
Minority interest------
Other liabilities, total1.684.121.54
Total liabilities745514
SHAREHOLDERS EQUITY
Common stock0.040.030.02
Additional paid-in capital411290194
Retained earnings (accumulated deficit)(309)(213)(124)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1027770
Total liabilities & shareholders' equity17613184
Total common shares outstanding442821
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.